Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 33
Filter
1.
J Nucl Cardiol ; 28(4): 1692-1701, 2021 08.
Article in English | MEDLINE | ID: mdl-31529384

ABSTRACT

PURPOSE: Cardiac 123I-MIBG image interpretation is affected by population differences and technical factors. We recruited older adults without cognitive decline and compared their cardiac MIBG uptake with results from the literature. METHODS: Phantom calibration confirmed that cardiac uptake results from Japan could be applied to our center. We recruited 31 controls, 17 individuals with dementia with Lewy bodies (DLB) and 15 with Alzheimer's disease (AD). Images were acquired 20 minutes and four hours after injection using Siemens cameras with medium-energy low-penetration (MELP) collimators. Local normal heart-to-mediastinum (HMR) ratios were compared to Japanese results. RESULTS: Siemens gamma cameras with MELP collimators should give HMRs very close to the calibrated values used in Japan. However, our cut-offs with controls were lower at 2.07 for early and 1.86 for delayed images. Applying our lower cut-off to the dementia patients may increase the specificity of cardiac MIBG imaging for DLB diagnosis in a UK population without reducing sensitivity. CONCLUSIONS: Our local HMR cut-off values are lower than in Japan, higher than in a large US study but similar to those found in another UK center. UK centers using other cameras and collimators may need to use different cut-offs to apply our results.


Subject(s)
3-Iodobenzylguanidine/pharmacokinetics , Alzheimer Disease/metabolism , Iodine Radioisotopes/pharmacokinetics , Lewy Body Disease/metabolism , Radiopharmaceuticals/metabolism , Adult , Age Factors , Aged , Aged, 80 and over , Alzheimer Disease/diagnostic imaging , Case-Control Studies , Cohort Studies , Female , Humans , Lewy Body Disease/diagnostic imaging , Male , Middle Aged
2.
Parkinsonism Relat Disord ; 62: 79-84, 2019 05.
Article in English | MEDLINE | ID: mdl-30709778

ABSTRACT

OBJECTIVE: To determine the utility of 123I-metaiodobenzylguanidine cardiac scintigraphy (MIBG), and optimum heart: mediastinum ratio (HMR) for differentiating dementia with Lewy bodies (DLB) from Alzheimer's disease (AD) in a clinically representative population, comparing findings with those of 123I-2ß -carbomethoxy-3ß-(4-iodophenyl)-N-(3-fluoropropyl) nortropane (FP-CIT) SPECT. METHODS: We recruited subjects with probable DLB (n = 17) and probable AD (n = 16) from clinical services. Each participant underwent clinical examination, cardiac MIBG scintigraphy and FP-CIT SPECT. Diagnosis was made on the basis of clinical symptoms using validated criteria. Cardiac MIBG uptake was measured by the planar HMR, blind to clinical diagnosis, with values below a cut-off taken from a previous study (<2.2 at four hours) defining scans as abnormal. FP-CIT scans were blindly rated according to a visual rating scale. RESULTS: MIBG had a sensitivity, specificity and overall accuracy of 71%, 81% and 76% for distinguishing DLB from AD. FP-CIT demonstrated a sensitivity, specificity and accuracy of 82%, 88% and 85%. Using a lower HMR cut-off to distinguish between abnormal and normal MIBG scans improved the accuracy of MIBG, raising specificity (100%) and overall accuracy (85%) without compromising sensitivity (71%). Neither prescription of potentially interfering medications, nor a history of myocardial infarction (MI), had a significant effect on HMR. CONCLUSION: We found that MIBG did not demonstrate superior sensitivity and overall accuracy to FP-CIT. HMR cut-off influences biomarker utility, and clinical and Caucasian populations may require a lower cut-off than those reported elsewhere. Future MIBG studies should include clinically representative cohorts as neither medications nor previous MI appear to influence HMR.


Subject(s)
Alzheimer Disease/diagnosis , Dementia/diagnosis , Iodine Radioisotopes , Lewy Body Disease/diagnosis , Aged , Aged, 80 and over , Cohort Studies , Dementia/physiopathology , Diagnosis, Differential , Female , Humans , Iodine Radioisotopes/pharmacology , Lewy Body Disease/physiopathology , Male , Middle Aged , Myocardial Perfusion Imaging/methods
3.
J Health Econ ; 27(4): 959-972, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18207264

ABSTRACT

OBJECTIVES: This study estimates the value that clients place on methadone maintenance and how this value varies with the effectiveness of treatment and availability of case management. We provide the first estimate of the price elasticity of the demand for drug treatment. METHODS: We interviewed 241 heroin users who had been referred to, but had not yet entered, methadone maintenance treatment in Baltimore, Maryland. We asked each subject to state a preference among three hypothetical treatment programs that varied across three domains: weekly fee paid by the client out-of-pocket ($5-$100), presence/absence of case management, and time spent heroin-free (3-24 months). Each subject was asked to complete 18 orthogonal comparisons. Subsequently each subject was asked if they likely would enroll in their preferred choice among the set of three. We computed the expected willingness to pay (WTP) as the probability of enrollment times the fee considered in each choice considered from a multivariate logistic model that controlled for product attributes. We also estimated the price elasticity of demand. RESULTS: The median expected fee subjects were willing to pay for a program that offered 3 months of heroin-free time was $7.30 per week, rising to $17.11 per week for programs that offered 24 months of heroin-free time. The availability of case management increased median WTP by $5.64 per week. The price elasticity was -0.39 (S.E. 0.042). CONCLUSIONS: Clients will pay more for higher rates of treatment success and for the presence of case management. Clients are willing to pay for drug treatment but the median willingness to pay falls short of the estimated program costs of $82 per week. Thus a combined approach of user fees and subsidization may be the optimal financing strategy for the drug treatment system.


Subject(s)
Financing, Personal , Patient Acceptance of Health Care , Rehabilitation/economics , Substance-Related Disorders/rehabilitation , Adult , Female , Humans , Interviews as Topic , Male , Middle Aged
4.
Br J Dermatol ; 156(6): 1350-2, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17535234

ABSTRACT

BACKGROUND: Skin imaging devices to aid melanoma diagnosis have been developed in recent years but few have been assessed clinically. OBJECTIVES: To investigate if a spectrophotometric skin imaging device, the SIAscope, could increase a dermatologist's ability to distinguish melanoma from nonmelanoma in a melanoma screening clinic. METHODS: Eight hundred and eighty-one pigmented lesions from 860 patients were prospectively assessed clinically and with the aid of the spectrophotometric device by a dermatologist. Assessment before and after spectrophotometric imaging was made and compared with histology, where available, or with the clinical diagnosis of a dermatologist with 20 years of experience. RESULTS: One hundred and seventy-nine biopsies were performed, with 31 melanomas diagnosed. Sensitivity and specificity for melanoma diagnosis before and after spectrophotometry were 94% and 91% vs. 87% and 91%, respectively, with no significant difference in the area under the receiver operating characteristic curves (0.932 and 0.929). CONCLUSIONS: Our study provides no evidence for the use of SIAscope by dermatologists to help distinguish melanoma from benign lesions.


Subject(s)
Melanoma/diagnosis , Pigmentation Disorders/diagnosis , Skin Neoplasms/diagnosis , Spectrophotometry/instrumentation , Adult , Area Under Curve , Diagnosis, Differential , Female , Humans , Male , Melanins/analysis , Melanoma/chemistry , Middle Aged , Pilot Projects , Sensitivity and Specificity , Skin Neoplasms/chemistry
5.
Clin Exp Dermatol ; 32(4): 359-64, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17376206

ABSTRACT

BACKGROUND: In Europe, where sunscreens are classified as cosmetics, products may contain one or several of 27 permitted 'ultraviolet filters'. We were unable to find published data on the frequency of usage of individual ultraviolet (UV)-absorbing chemicals in currently available sunscreens. AIM: To record the active ingredients and labelling characteristics of sunscreens available in the UK. METHODS: In 2005, two dermatologists visited seven retail outlets, which stocked a large range of sunscreens. Manufacturers were also contacted. For each product, the names of UV-protective ingredients and the labelling information, including sun protection factor (SPF), UVA protection and age group for which the product was marketed were recorded. RESULTS: Data on 308 skin sunscreen products and 21 lip sunscreens were recorded. For skin products, the SPF ranged from 2 to 60. In total, 23 different UV-absorbing ingredients were found, 4 of which were found in > 25% of products. The child and baby skin sunscreens (n = 52) had a significantly higher median SPF of 40, compared with 15 for the remaining 256 adult products (P < 0.001). The number of UV-absorbing chemicals and the frequency of those commonly used did not differ substantially between child and adult products. Of skin sunscreens marketed for babies, 60% contained 2-6 UV-absorbing chemicals. Nearly half of the skin sunscreens contained at least one of nine UV-absorbing chemicals not available in patch testing formulations from commercial suppliers. CONCLUSIONS: The results of this survey indicate current sunscreen content and labelling, and are a benchmark from which new developments can be tracked. More standard sunscreen labelling, particularly separate listing of active ingredients, would be helpful. It was surprising to find UV-absorbing chemicals in products sold for use on babies.


Subject(s)
Cosmetics/analysis , Drug Labeling/standards , Sunscreening Agents/chemistry , Adult , Child , Child, Preschool , Humans , Infant , Sunscreening Agents/standards , United Kingdom
6.
Br J Dermatol ; 151(5): 1066-70, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15541086

ABSTRACT

BACKGROUND: Provocation testing is frequently performed during investigation of patients with suspected polymorphic light eruption (PLE). Techniques are not standardized between centres. OBJECTIVES: We sought to evaluate the efficacy of different fluorescent ultraviolet (UV) radiation lamps for provocation testing in PLE. METHODS: We analysed results in 68 patients referred consecutively for phototesting in whom a diagnosis of PLE seemed likely based on clinical history. Patients' case notes were reviewed and responses recorded to provocation testing on forearm skin over three consecutive days using broadband UVA, narrowband and broadband UVB lamps. RESULTS: A positive papular response to broadband UVA exposure was seen in 38 patients [56%, estimated 95% population confidence interval (CI) 43-67.9]. Thirty-four patients (50%) had a positive papular response to narrowband UVB exposure (95% CI 37.6-62.4). The probability of a positive provocation test following irradiation with both lamps was 80.9% (95% CI 69.5-89.4). From April 1999, 34 patients also had provocation testing with broadband UVB. Although six patients (18%) had a positive papular response, they all showed a positive response to one or both of the other lamp types. CONCLUSIONS: Provocation testing with fluorescent UVA and UVB lamps is a cheap and readily available method that can be used as a diagnostic aid to investigate patients with suspected PLE. Using both broadband UVA and narrowband UVB lamps for testing increases the likelihood of confirming the diagnosis than if either lamp is used alone.


Subject(s)
Photosensitivity Disorders/diagnosis , Ultraviolet Rays , Adolescent , Adult , Child , Erythema/etiology , Female , Humans , Male , Middle Aged , Radiation Dosage , Radiation Injuries/etiology , Skin/radiation effects , Skin Tests/instrumentation , Skin Tests/methods
7.
Br J Dermatol ; 151(4): 873-6, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15491429

ABSTRACT

BACKGROUND: Photosensitive patients sometimes report disease flares during journeys by car. Window glass blocks all UVB but not all UVA. All car windscreens are made from laminated glass. Side and rear windows are usually made of nonlaminated glass. OBJECTIVES: To determine which types of glass provide most protection from UVA with particular reference to the implications for patients with polymorphic light eruption (PLE). METHODS: The percentage transmission of UVA was determined for a selection of glass, both laminated and nonlaminated, and with differing colour tints. RESULTS: Laminated glass transmits less UVA than nonlaminated glass. Tinted glass transmits less UVA than clear glass. Nonlaminated clear glass transmitted the highest percentage of UVA (62.8%) and grey laminated glass the lowest (0.9%). A dose of 5 J cm(-2) UVA, enough to trigger PLE in some patients, could be transmitted through clear nonlaminated glass in 30 min but would take 50 h through grey laminated glass. CONCLUSION: Patients with severe UVA-induced PLE and other photosensitivity disorders may have disease flares from solar UVA transmission through side-window glass. Protective measures such as wearing long-sleeved clothing, keeping the arm beneath the bottom of the window aperture, or choosing tinted and laminated car windows may be helpful.


Subject(s)
Automobiles , Glass , Photosensitivity Disorders/etiology , Ultraviolet Rays/adverse effects , Coated Materials, Biocompatible , Humans , Photosensitivity Disorders/prevention & control , Radiation Protection , Scattering, Radiation , Travel
8.
Br J Dermatol ; 150(6): 1162-6, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15214904

ABSTRACT

BACKGROUND: Phototherapy units should regularly use hand-held ultraviolet (UV) meters to assess the output of treatment lamps, and these meters should be accurately calibrated. Several medical physics departments in the U.K. can calibrate UV meters traceable to national standards, but there is concern that there may be disagreement among departments. In particular, there may be difficulty in calibration for narrow-band UVB phototherapy lamps (TL-01). OBJECTIVES: To ascertain the level of agreement in UV meter calibration at expert centres in the U.K., and to survey methodology at these centres, consider sources of errors and to make recommendations on calibration methods. METHODS: The same UV meter with two detectors (for UVA and UVB) was calibrated by seven medical physics departments. A questionnaire on methods was also distributed and measured spectral outputs from each centre were examined. RESULTS: The calibration factors for the meter varied by +/- 18% for the UVA detector and by +/- 60% for the UVB detector (2 standard deviations). Six centres performed calibration using a spectroradiometer and one centre used a reference meter method. The spectra of lamps used for calibration were similar. For the spectroradiometric methods there were some differences in methodology and instrumentation that may account for the differences in calibration factors. CONCLUSIONS: UV meter calibration in the U.K. shows unacceptable variability, particularly for TL-01 lamps. An accuracy of around of +/- 10% would be clinically acceptable and should be technically achievable.


Subject(s)
PUVA Therapy/instrumentation , Phototherapy/instrumentation , Calibration , Humans , Maintenance , Physical Phenomena , Physics , Radiotherapy Dosage , Ultraviolet Rays
9.
Br J Dermatol ; 147(5): 966-72, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12410708

ABSTRACT

BACKGROUND: Sunbeds fitted with conventional ultraviolet (UV) A lamps that have about 0.7% UVB emission are widely used by patients with psoriasis even though they are minimally effective. A new fluorescent sunbed lamp has been developed that emits a higher proportion of UVB (4.6%) than conventional lamps and also requires shorter exposure times to achieve equivalent erythema. OBJECTIVES: To perform a randomized, within-patient comparison of conventional sunbed lamps (Cleo Performance) with the new lamps (Cleo Natural) in the treatment of psoriasis. METHODS: A sunbed and canopy unit were modified to allow exposure to Cleo Performance lamps on one side of the body (front and back) and Cleo Natural lamps to the other side of the body. Two studies were done. In study 1, equal erythemal doses were given from the two lamp types. In study 2, equal exposure times were given. We treated 34 patients with psoriasis, giving 12 exposures over a period of 4 weeks. Assessment was made using a modified Psoriasis Area and Severity Index (PASI) score, individual plaque assessment and patient questionnaire. RESULTS: Fourteen patients completed each study. In study 1, there was no significant difference in median improvement in half-body PASI score for the two lamp types. In study 2, there was a significant difference in PASI score improvement between the two lamps (median Cleo Performance change minus median Cleo Natural change was - 2.20; 95% confidence interval - 3.75 to - 0.65; P = 0.006). CONCLUSIONS: That no difference in response was found when equal erythemal doses were given suggests that the spectral emission of the Cleo Natural lamp is of no greater advantage for clearance of psoriasis than conventional lamps. However, the Cleo Natural lamps are more erythemally powerful, and exposure times similar to those used in conventional sunbeds result in a significant improvement of psoriasis. The risk of non-melanoma skin cancer from different patterns of exposure to Cleo Natural lamps can be estimated using established numerical models.


Subject(s)
Psoriasis/radiotherapy , Ultraviolet Therapy/instrumentation , Adolescent , Adult , Aged , Double-Blind Method , Erythema/etiology , Female , Humans , Male , Middle Aged , Patient Satisfaction , Psoriasis/pathology , Radiation Injuries/etiology , Radiotherapy Dosage , Severity of Illness Index , Surveys and Questionnaires , Treatment Outcome , Ultraviolet Therapy/methods
10.
Acta Neurol Scand ; 105(5): 355-64, 2002 May.
Article in English | MEDLINE | ID: mdl-11982486

ABSTRACT

OBJECTIVE: The occurrence of high signal abnormalities on T2 weighted images is strongly age related. The diagnostic value of these changes in a younger population with dementia is not currently known. We studied the potential of high signal changes on magnetic resonance imaging (MRI) in differentiating Alzheimer's disease (AD), frontotemporal dementia (FTD) and vascular dementia (VaD) in younger patients. METHODS: High signal abnormalities were rated, using a previously validated scale, from hard copies of T2 weighted axial images of 102 patients with AD (n=49), VaD (n=31), FTD (n=22) (mean ages 63-65 years). RESULTS: High signal abnormalities were widespread across AD, VaD and FTD. Although they were most frequent and most severe in the VaD group only lacunes and grade III deep white matter hyperintensities (DWMH) were specific for these patients. CONCLUSIONS: High signal changes on T2 weighted images on MRI are common across degenerative (AD and FTD) and vascular dementias. Although lacunes and grade III DWMH are specific for VaD, the low sensitivities (sensitivities: for lacunes, 0.32; for grade III DWMH, 0.16) limit their use as diagnostic markers for VaD. High signal changes on MRI should be interpreted with caution in dementias. Their presence, even in younger patients, should not deter one from diagnosing AD or FTD.


Subject(s)
Alzheimer Disease/diagnosis , Dementia, Vascular/diagnosis , Frontal Lobe/pathology , Magnetic Resonance Imaging , Temporal Lobe/pathology , Aged , Basal Ganglia/pathology , Female , Humans , Male , Middle Aged , Severity of Illness Index
11.
Br J Dermatol ; 146(5): 755-63, 2002 May.
Article in English | MEDLINE | ID: mdl-12000370

ABSTRACT

This report examines the dosimetry of ultraviolet (UV) radiation applied to dermatological treatments, and considers the definition of the radiation quantities and their measurement. Guidelines are offered for preferred measurement techniques and standard methods of dosimetry. The recommendations have been graded according to the American Joint Committee on Cancer classification of strength of recommendation and quality of evidence (summarized in Appendix 5).


Subject(s)
Radiometry/methods , Skin Diseases/radiotherapy , Ultraviolet Therapy , Humans , Radiometry/standards , Radiotherapy Dosage
12.
Acta Neurol Scand ; 105(4): 261-9, 2002 Apr.
Article in English | MEDLINE | ID: mdl-11939938

ABSTRACT

OBJECTIVES: Alzheimer's disease (AD), frontotemporal dementia (FTD) and vascular dementia (VaD) are the three most common causes of young onset dementias. Most neuroimaging studies of these disorders have involved comparisons with normal controls. The aims of this study were to examine the clinical diagnostic value of magnetic resonance imaging (MRI) and single photon emission computed tomography (SPECT) (in combination and in isolation) in the differentiation of one form of dementia from another from amongst a group of AD, FTD and VaD. METHODS: T1 weighted MRI images and 99mTc-HMPAO SPECT images were obtained from consecutive patients with FTD (n=21), AD (n=23) and VaD (n=20) and rated visually by experienced neuroradiologists and nuclear medicine physicians. RESULTS: Asymmetrical atrophy was seen only in FTD. Frontotemporal dementia patients were the most atrophic whereas severe atrophy was rarely observed in VaD. Severe frontal atrophy (unilaterally or bilaterally) and/or asymmetrical atrophy on MRI is highly diagnostic (sensitivity 0.71, specificity 0.93, LR 10.24) of FTD from within a group of FTD and non-FTD (AD, VaD) patients. Mild or severe parietal atrophy with severe reduction in parietal regional cerebral blood flow on SPECT is diagnostic (sensitivity 0.71, specificity 0.76, LR 3.02) of AD from within a group of AD and non-AD (VaD, FTD) patients. CONCLUSION: Anatomical (MRI) and functional (SPECT) imaging provide different information and a combination of these modalities improves diagnostic specificity.


Subject(s)
Alzheimer Disease/diagnosis , Cerebrovascular Circulation , Dementia, Vascular/diagnosis , Dementia/diagnosis , Magnetic Resonance Imaging , Tomography, Emission-Computed, Single-Photon , Aged , Alzheimer Disease/diagnostic imaging , Alzheimer Disease/physiopathology , Atrophy , Dementia/diagnostic imaging , Dementia/physiopathology , Dementia, Vascular/diagnostic imaging , Dementia, Vascular/physiopathology , Female , Frontal Lobe/diagnostic imaging , Frontal Lobe/pathology , Frontal Lobe/physiopathology , Humans , Male , Middle Aged , Parietal Lobe/diagnostic imaging , Parietal Lobe/pathology , Parietal Lobe/physiopathology , Temporal Lobe/diagnostic imaging , Temporal Lobe/pathology , Temporal Lobe/physiopathology
13.
J Invest Dermatol ; 117(5): 1318-21, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11710951

ABSTRACT

Psoriasis may be treated with ultraviolet B from lamps that have a broad emission spectrum or, more effectively, with lamps that have a narrow emission spectrum at 311 +/- 2 nm. There are conflicting reports of either greater or lesser burning episodes with narrow-band compared to broad-band ultraviolet B, even when treatments are based on predetermined minimal erythema dose measurements. This suggests that either the characteristics of the dose-response curve for erythema or the time course for erythema may be different for the two lamps. We examined the erythemal response to narrow-band and broad-band ultraviolet B in 12 patients with psoriasis. A geometric series of 10 doses from each lamp type were used on nonlesional skin on the back. Dose-response curves were constructed from reflectance measurements of erythema at 24 h and 72 h after irradiation. No significant difference was found in steepness of the erythema dose-response curve for the two lamps at 24 or 72 h. Persistence of erythema was assessed as the percentage of erythema remaining at 72 h. The mean persistence was 63% for narrow-band and 64% for broad-band lamps (p = 0.94). Therefore, in terms of erythemal response, no evidence has been found for a difference in burning potential for the two lamps.


Subject(s)
Erythema/etiology , Radiation Injuries , Ultraviolet Rays , Adult , Dose-Response Relationship, Radiation , Erythema/pathology , Female , Humans , Male , Middle Aged , Time Factors
14.
Acta Neurol Scand ; 101(1): 53-6, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10660153

ABSTRACT

OBJECTIVES: Dementia with Lewy bodies (DLB) is the second commonest neurodegenerative cause of dementia. While there is consensus on the clinical diagnostic criteria for DLB, the use of EEG to increase the diagnostic sensitivity has not been substantiated. MATERIAL AND METHODS: We studied the resting EEG findings in 18 consecutive patients with DLB and compared them with a control group of 20 patients with "probable" Alzheimer's disease (AD). We aimed to evaluate the use of EEG in a representative sample of patients with DLB. RESULTS: All patients with DLB fulfilled accepted clinical criteria for DLB. The DLB group had a more severe dementia than the AD group, as measured by the Mini-Mental State Examination (MMSE) test (DLB mean MMSE 9.4 and AD mean MMSE 17.2) despite a similar duration of overall severity of illness. The EEG was slow in both groups, predominantly in the 4-7 Hz range. Although there was no statistically significant difference in the EEG findings between the DLB and AD groups, there was a correlation between the EEG score and MMSE score (Spearman Rank correlation rs = -0.61, P < 0.001). CONCLUSION: These findings suggest that although patients with DLB have a more aggressive course than AD, EEG abnormalities do not differ in the 2 groups. However, we believe the EEG provides important supporting diagnostic information in DLB.


Subject(s)
Electroencephalography , Lewy Body Disease/diagnosis , Aged , Alzheimer Disease/diagnosis , Alzheimer Disease/physiopathology , Cerebral Cortex/physiopathology , Diagnosis, Differential , Dominance, Cerebral/physiology , Evoked Potentials/physiology , Female , Humans , Lewy Body Disease/physiopathology , Male , Mental Status Schedule , Middle Aged , Sensitivity and Specificity , Signal Processing, Computer-Assisted
15.
Subst Use Misuse ; 35(9): 1207-25, 2000 Aug.
Article in English | MEDLINE | ID: mdl-11349682

ABSTRACT

The objective of the present study was to estimate the strength of the associations between recent weapon carrying and alcohol, cigarette, and illicit drug use among US Virgin Islands (USVI) youth. Data from 1,124 students in Grades 7-12 were analyzed using the conditional form of multiple logistic regression. Compared with youth who did not carry a weapon. youth who carried a weapon were more likely to be male and recent cigarette, alcohol, and illicit drug users. After matching on school and controlling for age, sex, race, neigborhood characteristics, and affiliation with friends who use alcohol and illegal drugs, the associations with cigarette smoking and illicit drug use remained both moderate and statistically significant (odds ratio [OR] = 4.31, p < .001; OR = 2.99, p < .001, respectively). These findings identify a potentially high-risk population that could be targeted for interventions to reduce weapon carrying among youth.


Subject(s)
Firearms , Substance-Related Disorders/epidemiology , Adolescent , Child , Cross-Sectional Studies , Female , Humans , Male , Prevalence , Risk-Taking , Surveys and Questionnaires , United States/epidemiology , United States Virgin Islands/epidemiology
16.
J Neurol Neurosurg Psychiatry ; 66(2): 184-8, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10071097

ABSTRACT

OBJECTIVES: The diagnosis of Alzheimer's disease (AD) is now reliant on the use of NINCDS-ADRDA criteria. Other diseases causing dementia are being increasingly recognised--for example, frontotemporal dementia (FTD). Historically, these disorders have not been clearly demarcated from AD. This study assesses the capability of the NINCDS-ADRDA criteria to accurately distinguish AD from FTD in a series of pathologically proved cases. METHODS: The case records of 56 patients (30 with AD, 26 with FTD) who had undergone neuropsychological evaluation, brain imaging, and ultimately postmortem, were assessed in terms of whether at initial diagnosis the NINCDS-ADRDA criteria were successful in diagnosing those patients who had AD and excluding those who did not. RESULTS: (1) The overall sensitivity of the NINCDS-ADRDA criteria in diagnosing "probable" AD from 56 patients with cortical dementia (AD and FTD) was 0.93. However, the specificity was only 0.23; most patients with FTD also fulfilled NINCDS-ADRDA criteria for AD. (2) Cognitive deficits in the realms of orientation and praxis significantly increased the odds of a patient having AD compared with FTD, whereas deficits in problem solving significantly decreased the odds. Neuropsychological impairments in the domains of attention, language, perception, and memory as defined in the NINCDS-ADRDA statement did not contribute to the clinical differentiation of AD and FTD. CONCLUSION: NINCDS-ADRDA criteria fail accurately to differentiate AD from FTD. Suggestions to improve the diagnostic specificity of the current criteria are made.


Subject(s)
Alzheimer Disease/diagnosis , Dementia/diagnosis , Frontal Lobe , Temporal Lobe , Aged , Diagnosis, Differential , Female , Humans , Male , Middle Aged
17.
J Neurol Neurosurg Psychiatry ; 64(3): 306-13, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9527139

ABSTRACT

OBJECTIVES: To provide the clinician with a guide to the clinical utility of 99mTc-HMPAO single photon emission computed tomography (SPECT) and to the interpretation of specific test results in the differential diagnosis of dementia. METHODS: Three hundred and sixty three patients with dementia were studied prospectively for a median three (range 1-6) years and classified into disease groups on the basis of established clinical criteria. The degree to which different patterns of cerebral blood flow (CBF) abnormality found on 99mTc-HMPAO SPECT imaging at the time of initial patient presentation modified clinical diagnoses was determined by calculating the likelihood ratios for pairwise disease group comparisons. The optimal clinical usage of 99mTc-HMPAO SPECT was determined by calculating the percentage of significant test results for each pairwise disease group comparison. RESULTS: Bilateral posterior CBF abnormality was found to significantly increase the odds of a patient having Alzheimer's disease as opposed to vascular dementia or frontotemporal dementia. Bilateral anterior CBF abnormality significantly increased the odds of a patient having frontotemporal dementia as opposed to Alzheimer's disease, vascular dementia, or Lewy body disease. "Patchy" CBF changes significantly increased the odds of a patient having vascular dementia as opposed to Alzheimer's disease. Unilateral anterior, unilateral anterior plus unilateral posterior, and generalised CBF abnormality failed to contribute to the differentiation of any of these forms of dementia. CONCLUSIONS: 99mTc-HMPAO SPECT was found to be most useful in distinguishing Alzheimer's disease from vascular dementia and fronto temporal dementia, and least useful in differentiating between Alzheimer's disease and Lewy body disease, and between vascular dementia, frontotemporal dementia, and progressive aphasia. It is suggested that CBF SPECT should be used selectively and as an adjunct to clinical evaluation and CT.


Subject(s)
Dementia/diagnostic imaging , Technetium Tc 99m Exametazime , Tomography, Emission-Computed, Single-Photon , Aged , Alzheimer Disease/diagnostic imaging , Aphasia, Primary Progressive/diagnostic imaging , Dementia/classification , Dementia/etiology , Dementia, Vascular/diagnostic imaging , Diagnosis, Differential , Female , Humans , Likelihood Functions , Male , Middle Aged , Odds Ratio , Parkinson Disease/diagnostic imaging , Prospective Studies , Reproducibility of Results , Sensitivity and Specificity
18.
Nucl Med Commun ; 19(10): 999-1004, 1998 Oct.
Article in English | MEDLINE | ID: mdl-10234680

ABSTRACT

This paper considers the different statistics that can be derived from studies on the value of diagnostic tests. Well-accepted quantities, such as sensitivity and specificity, are reviewed and the value of the likelihood ratio in communicating particular test results is highlighted. A new quantity, the 'diagnostic value index', is proposed and various examples of its application in nuclear medicine studies are presented. This new index is based on a weighted average of the likelihood ratios for all possible outcomes of the test, the average being weighted according to how frequently a particular outcome occurs. This index provides an objective and quantitative means of comparing the diagnostic value of different tests, or of comparing the value of a given test in different patient groups. It is hoped that this will be a useful aid to clinical decision-making concerning referrals for diagnostic tests.


Subject(s)
Coronary Disease/diagnostic imaging , Diagnosis , Models, Statistical , Pulmonary Embolism/diagnostic imaging , Coronary Disease/diagnosis , Electrocardiography/standards , Exercise Test , Heart/diagnostic imaging , Humans , Likelihood Functions , Predictive Value of Tests , Radionuclide Imaging/standards , Reproducibility of Results , Sensitivity and Specificity
19.
J Neurol ; 244(6): 349-59, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9249619

ABSTRACT

The purpose of this study was to investigate patterns of 99mTc-HMPAO single-photon emission computed tomography (SPECT) abnormality in Lewy body disease (LBD) and to compare findings with those encountered in Alzheimer's disease (AD). The study group comprised 20 consecutive patient referrals fulfilling clinical criteria for LBD. All patients had fluctuating cognitive impairment and 'subcortical' dysfunction with or without perceptuospatial and/or linguistic impairment. Six patients had asymmetrical signs of parkinsonism (three left-sided and three right-sided), and 14 patients had symmetrical features of extrapyramidal involvement. 99mTc-HMPAO SPECT imaging was performed on LBD patients and findings compared with those of 57 patients with 'probable' AD and 11 normal age-matched controls. Within the LBD and AD groups, patterns of cortical and subcortical blood-flow abnormality were compared with patterns of cognitive and neurological breakdown. LBD was associated with bilateral posterior cortical blood flow abnormality, a pattern strikingly similar to that found in AD. Within the LBD group, cortical blood-flow abnormality was found to reflect patterns of neurological dysfunction (parkinsonism) indicative of subcortical involvement. In contrast, cortical blood-flow changes did not reflect patterns of neuropsychological impairment suggestive of cortical dysfunction. Within the AD group, cortical blood-flow changes were mirrored by the pattern of neuropsychological impairment. Findings support the notion that cortical blood-flow abnormality in LBD might reflect a combination of direct cortical pathology and cortical deafferentation secondary to subcortical Lewy body pathology. It would appear that 99mTc-HMPAO SPECT imaging is of limited value in the clinical differentiation of LBD and AD.


Subject(s)
Parkinson Disease/diagnostic imaging , Tomography, Emission-Computed, Single-Photon/methods , Aged , Alzheimer Disease , Analysis of Variance , Case-Control Studies , Female , Humans , Male , Middle Aged , Organotechnetium Compounds , Oximes , Technetium Tc 99m Exametazime
SELECTION OF CITATIONS
SEARCH DETAIL
...